Navigation Links
CORD:USE Cord Blood Bank Announces the Addition of Dr. John Wagner, a Pioneer in the Use of Umbilical Cord Blood Stem Cells, to Its Scientific Advisory Board
Date:1/30/2008

ORLANDO, Fla., Jan. 30 /PRNewswire/ -- John Wagner, M.D., recognized as a leader in the field of cord blood stem cell transplantation, has joined the team at CORD:USE Cord Blood Bank. Dr. Wagner's extensive experience and knowledge in transplant medicine and stem cell biology will provide a significant contribution to CORD:USE.

"We're honored and fortunate to have him as a member of our distinguished team," says Edward Guindi, M.D., President and CEO of CORD:USE Cord Blood Bank.

Dr. Wagner is internationally recognized as an expert in the field of stem cells and use of unrelated hematopoietic stem cell transplant. He is a professor of Pediatrics and the Director of the Division of Hematology- Oncology and Blood and Marrow Transplantation at the University of Minnesota. He is also the Scientific Director of Clinical Research of the Stem Cell Institute and Director of the Center of Molecular and Cellular Therapeutics.

Dr. Wagner has played a considerable role in the development and expansion of the applications of cord blood stem cells. His investigations on the simultaneous use of two cord blood units for transplantation in adults has made it possible for nearly all patients to benefit from cord blood stem cell transplantation who otherwise would not have been candidates for this therapy.

"Without question, I look forward to working with such a distinguished board of scientific advisors and the impressive team at CORD:USE," says Dr. Wagner. "Cord blood stem cells have already played an extremely important role in the treatment of thousands of patients, and I foresee the uses of cord blood expanding, such as in the field of regenerative medicine and tissue repair. The experience and expertise of the team at CORD:USE will help ensure that CORD:USE remains a leader in the field."

Dr. Wagner joins other highly-respected leaders in the field of cord blood stem cell transplantation at CORD:USE. Dr. Joanne Kurtzberg is the Director
'/>"/>

SOURCE CORD:USE Cord Blood Bank, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
2. Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes
3. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
4. The International Diabetes Federation (IDF) Recommends Tighter Control of Blood Glucose Levels After Meals in People With Diabetes
5. CDC Awards NATT Funding to Improve Blood Clot Awareness
6. FDA Clears OmniWave(TM) Endovascular System for Clot Removal in Peripheral Blood Vessels
7. Cellestis Receives FDA Approval for Blood Test for Detecting Tuberculosis
8. Blood Donations in U.S. Testing Positive for Chagas Disease
9. One of Nations Oldest Blood Services Providers Turns to Sysmex America
10. ExonHit Completes a Prototype to Detect Alzheimers Disease From Blood
11. AspenBio Pharma Pursues FDA 510(k) Application Pathway for Appendicitis Blood Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...s at Singapore,s Institute of Bioengineering and N...of imidazolium salts (IMSs), which suggest that th...nd treatment. , The report on the redox propert...merican Chemical Society . , In a separate study...tion , IBN researchers reported the first use of t...
(Date:12/2/2008)... Ariz., Dec. 2 MedPredict Market R...etitive intelligence and market,research, has pub...nsight for,pharma and biotech companies with a st...erapies. This report, entitled Thought Leader Ins...sed on 9 interviews conducted with PD,experts fro...
(Date:12/2/2008)... Calif., Dec. 2 Bionovo,... focused on the discovery and,development of safe...h and,cancer, announced that Isaac Cohen, Chairma...iew of the Company at the 20th Annual Piper Jaffra...r 3, 2008. The event will be held at,the New Yor...
(Date:12/2/2008)...A, Dec. 2 eResearchTechn...rovider of centralized ECG and eClinical,technolo... biotechnology,medical device and related indust...y, the Company,s President and Chief Executive Off...ncial Officer, are scheduled to present at,the Pi...
Breaking Biology Technology:New uses for imidazolium salts in medicine and alternative energy 2New uses for imidazolium salts in medicine and alternative energy 3New Report Provides Expert Analysis of Recent Advances and Setbacks in Parkinson's Disease Drug Development 2Bionovo to Present at the Piper Jaffray Healthcare Conference 2eResearchTechnology, Inc. to Present at the Piper Jaffray Health Care Conference on December 2, 2008 2
...in-based health care imaging software and services... PACS version 1.2.7. The new version features enh...on tools, image viewer plug-in and automated acces...d an electronic medical record makes provision of ...desktop highly desirable," said William Stafford, ...
...nology Council has published the first-ever magazi...-page publication highlights the states research b..., quality of life, key contacts and the I-Q Corrid...t. Paul. , ,The Wisconsin Technology Network has ...onsin The Smart Choice, over the next few weeks. ...
...an, president and CEO of the University of Wiscons...cal affairs for UW Medical School was the kick-off.... In this interview with WTN, Dr. Grossman discuss...lumes of data but, at the same time a Knowledge Ga...n is board certified in internal medicine, pulmona...
...nce Sept. 16-17 at the Monona Terrace on how games...aims to present successful projects in which games...s Initiative , the Academic Advanced Distributed ...ientists Learning Federation Project are co-spon...lity development of a new generation of game-based...
Other Biology Technology:Life Science: From Chicago to the Twin Cities: All tech roads lead to Wisconsin 2Life Science: From Chicago to the Twin Cities: All tech roads lead to Wisconsin 3WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation 2WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation 3WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation 4WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation 5
(Date:12/2/2008)...OUSTON, Dec. 2, 2008 Scientists and engineers fro... and energy will come together Dec. 8, along with...xplore synergies in moving oil and pumping blood. ... heart must pump blood through the body. Both sys...vessels), free of blockages or corrosion, to funct...
(Date:12/2/2008)...ew Haven, Conn.Organizations in the United States ...from climate change are not adapting enough to the...o a Yale report. , "Despite a half century of cl...ed temperature and precipitation patterns and has ... impacts, and despite a near certainty that the Un...
(Date:12/2/2008)...msterdam, 2 December 2008 - Elsevier is delighted ... be the official publisher of the quarterly peer-r...t ( www.elsevier.com/locate/esd ) on behalf of th...tainable development involves meeting present huma...ations. Energy is central to providing many of the...
(Date:12/2/2008)...erforming systematic reviews of nutrition related ...red in the field of medicine. In a new article, a ...ibe the steps, strengths, and limitations of syste...e factors that impact the results. , Systematic...ws, provide objective assessments with pre-specifi...
Breaking Biology News(10 mins):Using the other guy's toolkit: Similarities of pumping blood, oil examined 2Most US organizations not adapting to climate change 2Most US organizations not adapting to climate change 3New publishing partnership for Energy for Sustainable Development 2Experts discuss applying systematic review to the field of nutrition 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx 28R 29 GENTAMICIN TOPICAL for the Treatment of Moderate 1835 1Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx 28R 29 GENTAMICIN TOPICAL for the Treatment of Moderate 1835 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx 28R 29 GENTAMICIN TOPICAL for the Treatment of Moderate 1835 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx 28R 29 GENTAMICIN TOPICAL for the Treatment of Moderate 1835 4Compensation Risk Managers LLC Receives Notice of Administrative Action by New York Workers Compensation Board 17061 1Compensation Risk Managers LLC Receives Notice of Administrative Action by New York Workers Compensation Board 17061 2Compensation Risk Managers LLC Receives Notice of Administrative Action by New York Workers Compensation Board 17061 3ACS Systems Improving Delivery of Healthcare in Malta 17060 1ACS Systems Improving Delivery of Healthcare in Malta 17060 2ACS Systems Improving Delivery of Healthcare in Malta 17060 3Limited transparency in federal nanotech research may hamper development 4665 1Limited transparency in federal nanotech research may hamper development 4665 2
...ublished this week report findings that increase o... determined and how the speed of its development i...on the molecular and cellular pathways that act to...e, as well as on pathways that use that informatio...uring development. , The two studies are reported ...
...w ,dwarf belonging to the sea, in laboratoryScient...ir thinking about how Archaea, an ancient kingdom ...aintaining the global balance of nitrogen and carb... known to oxidize ammonia for energy and metaboliz...tively named, Nitrosopumilus maritimus, in the lab...
...w species, a team of international scientists leav... undiscovered treasures in the Mountains of Southw...ntain range. , "Expedition Everest: Mission Himal...ore one of the planet,s richest and most biologica...ith a month-long exploration in China where scient...
...irst medical uses of nanotechnology, a chemist and...diseases have joined forces to create an early det...most common cause of hospitalization among childre...sends about 120,000 children to the hospital in th...e-threatening in one case out of every 100, it inf...
Other Biology News:Hormones and growth: The control of body size and developmental growth rate in fruit flies 2Marine bacterium suspected to play role in global carbon and nitrogen cycles 2Team of international scientists departs today to discover the unknown in China's Himalayan region 2Team of international scientists departs today to discover the unknown in China's Himalayan region 3Quantum dots provide a faster, more sensitive method for detecting respiratory viral infections 2Quantum dots provide a faster, more sensitive method for detecting respiratory viral infections 3Quantum dots provide a faster, more sensitive method for detecting respiratory viral infections 4
ANTI ALPHA FSH:B
Beagle Serum • Beagle serum is collected from fasted Beagle canines of mixed sex over one year of age Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2EDTA N-08: Pot
MOUSE ANTI HUMAN MBP (67-74) Immunogen: Human myelin basic protein
MOUSE ANTI BOVINE TROPONIN I
Biology Products: